Dai Horiuchi, Ph.D.

University of California, San Francisco
email: none

Grants

Targeting MYC in Human Breast Cancer 2009 (Cycle 15)
Postdoctoral Fellowship 15FB-0006 $90,000


Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation.
  Periodical: Molecular Cell
  Author(s): Merrick KA, Wohlbold L, Zhang C, Allen JJ, Horiuchi D, et al
  Yr: 2011 Vol: 42 Nbr: 5 Pgs: 624-36
  Associated Grant: Targeting MYC in Human Breast Cancer
 
MYC pathway activation in triple-negative breast cancer is synthetic-lethal with CDK inhibition.
  Periodical: Journal of Experimental Medicine
  Author(s): Horiuchi, D., Kusdra, L., Huskey, N.E., Chandriani, S., Lenburg, M.E., Gonzalez-Angulo, A.
  Yr: Vol: 209 Nbr: Pgs: 679-696
  Associated Grant: Targeting MYC in Human Breast Cancer